REG - GetBusy PLC - Investor Presentation

GetbusyAnnouncement

27/10/2021 07:00

RNS Number : 3528Q
  
GetBusy PLC
  
27 October 2021
  
 

27 October 2021
GetBusy plc
Investor Presentation
GetBusy plc (AIM: GETB), a leader in productivity software for professionals and financial services, today announces that Daniel Rabie, CEO, and Paul Haworth, CFO, will provide a live presentation relating to the Company's recent bolt-on acquisitions and strategy overview, as announced on 19 October 2021, via the Investor Meet Company platform on 5 November 2021 at 11:00am GMT.
The presentation is open to all existing and potential shareholders and registration can be completed via the following link:  
https://www.investormeetcompany.com/getbusy-plc/register-investor
Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors who already follow GETBUSY PLC on the Investor Meet Company platform will automatically be invited.
 
Enquiries



GetBusy plc








investors@getbusy.com


















Liberum (Nomad and Broker)








Cameron Duncan / Lauren Kettle


+44 (0)20 3100 2000














Alma PR (Financial PR)


+44 (0) 20 3405 0205




Hilary Buchanan / Andy Bryant 
 







 
About GetBusy
GetBusy's suite of software applications streamline complex admin tasks for over 68,000 fee-earning professionals, enabling enhanced productivity and security anytime, anywhere.
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCDKABKKBDBKKB